Stock Events

Stock Events

Search...

Alnylam Pharmaceuticals (DUL.F) Q4 2022 Earnings

27OctConfirmed

Q1 2022

Q2 2022

Q3 2022

Q4 2022

-2.7

-2.23

-1.76

-1.3

Details

Expected EPS

-1.7958354

Actual EPS

-2.6987694

Surprise EPS

-0.9

Surprise Percent

+50.28%

Description

Alnylam Pharmaceuticals (DUL.F) has reported earnings of -2.6987694 per share for Q4 2022.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.